Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives.
Reliable and reproducible methods for the measurements of artemisinin and its derivatives in body fluids have proved difficult to develop. The available evidence suggests that all compounds are hydrolysed to a biologically active metabolite, dihydroartemisinin, which is eliminated rapidly. The role...
Autor principal: | White, N |
---|---|
Formato: | Conference item |
Publicado em: |
1994
|
Registos relacionados
-
Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia
Por: Lohy Das, J, et al.
Publicado em: (2017) -
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Por: André Daher, et al.
Publicado em: (2019-09-01) -
Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
Por: White, N, et al.
Publicado em: (1999) -
Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
Por: White, N, et al.
Publicado em: (1999) -
Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
Por: Das, J, et al.
Publicado em: (2018)